Acetylleucine (Standard)

Acetylleucine (Standard) is the analytical standard of Acetylleucine. This product is intended for research and analytical applications. Acetylleucine (N-Acetyl-DL-leucine), orally active compound, can be used for the research of acute vestibular vertigo, cerebellar ataxia and nystagmus[1][2].

Product Specifications

CAS Number

[99-15-0]

UNSPSC

12352100

Target

Drug Derivative; Reference Standards

Related Pathways

Others

Field of Research

Neurological Disease

Smiles

CC(C)CC(C(O)=O)NC(C)=O

Molecular Formula

C8H15NO3

Molecular Weight

173.21

References & Citations

[1]Feil K, et, al. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus. Cerebellum. 2016 Feb;15 (1) :38-42.|[2]Clément G, et, al. Effects of vestibular training on motion sickness, nystagmus, and subjective vertical. J Vestib Res. 2007;17 (5-6) :227-37.|[3]Günther L, et al. N-acetyl-L-leucine accelerates vestibular compensation after unilateral labyrinthectomy by action in the cerebellum and thalamus. PLoS One. 2015 Mar 24;10 (3) :e0120891.